Skip to main content
SpringerLink
Log in

G protein polymorphisms do not predict weight loss and improvement of hypertension in severely obese patients

  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

Both the gene encoding the α subunit of G stimulatory proteins (GNAS1) and the β3 subunit gene (GNB3) of G proteins are associated with obesity and/or hypertension. Moreover, the TT/TC825 polymorphism of GNB3 predicts greater weight loss than the CC825 polymorphism in obese patients (mean body mass index, 35 kg/m2) undergoing a structured nonpharmacologic weight loss program. Gastric banding enforces a low-calorie diet by diminishing the need for volitional adherence. It is unknown whether these polymorphisms predict the variable weight loss in patients after bariatric surgery. Three hundred and four severely obese patients (mean +- SEM age, 42 +- 1 years; 245 women and 59 men; mean +- SEM body mass index, 43.9 +- 0.3 kg/m2) followed prospectively for at least 3 years after surgery were genotyped for theGNB3C825T, G814A,andGNAS1T393 polymorphisms. All analyses were performed blinded to the phenotypic characteristics of the study group. Frequencies of polymorphisms were comparable to those previously published. No polymorphism studied predicted 3-year weight loss or was associated with high blood pressure in severely obese patients after gastric banding. Multivariate analysis of potentially confounding factors such as reoperation rate or use of sibutramine or orlistat revealed similar results (P > 0.1). Regardless of the mechanism(s) involved for these discordant findings, GNB3 C825T, G814A, and GNAS1 T393C polymorphisms do not seem to be reliable predictors of long-term weight loss.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Comuzzie AG, Allison DB. The search for human obesity genes. Science 1998;280:1374–1377.

    Article  PubMed  CAS  Google Scholar 

  2. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Geneva, Switzerland: 1998, World Health Organization, WHO/NUT/NCD/98.1.

  3. Nestle M. The ironic politics of obesity. Science 2003;299:781.

    Article  PubMed  CAS  Google Scholar 

  4. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497.

    Google Scholar 

  5. Klein S, Wadden T, Sugerman HJ. AGA technical review on obesity. Gastroenterology 2002;123:882–932.

    Article  PubMed  Google Scholar 

  6. Kral JG. Surgical treatment of obesity. In Bray GA, Bouchard C, James WPT, eds. Handbook of Obesity. New York: Marcel Dekker, 1998, pp 977–993.

    Google Scholar 

  7. Steffen R, Biertho L, Ricklin Th, et al. Laparoscopic adjustable gastric banding: A five-year prospective study. Obes Surg 2003;13:404–411.

    Article  PubMed  Google Scholar 

  8. Hauner H, Meier M, Jockel KH, et al. Prediction of successful weight reduction under sibutramine therapy through genotyping of the G-protein beta3 subunit gene (GNBS) C825T polymorphism. Pharmacogenetics 2003;13:453–459.

    Article  PubMed  CAS  Google Scholar 

  9. Frey U, Hauner H, Bachmann H, et al. Der G-Protein alpha s (GNAS1)T393C-Polymorphismus als Prädiktor für erfolgreiche Gewichtsreduktion und kardiovaskuläre Nebenwirkungen unter Therapie mit Sibutramin. Aktuel Ernaer 2003;28:311–347.

    Google Scholar 

  10. Rosskopf D, Manthey I, Habich C, et al. Identification and characterization of G beta 3s2, a novel splice variant of the G-protein beta 3 subunit. Biochem J 2003;371(Pt 1):223–232.

    Article  PubMed  CAS  Google Scholar 

  11. Siffert W. Cardiovascular pharmacogenetics: On the way toward individually tailored drug therapy. Kidney Int Suppl 2003;84:S168-S171.

    Article  PubMed  CAS  Google Scholar 

  12. Zill P, Baghai TC, Zwanzger P, et al. Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressant treatment. Neuroreport 2000; 11:1893–1897.

    Article  PubMed  CAS  Google Scholar 

  13. Schafers RF, Nurnberger J, Rutz A, et al. Haemodynamic characterization of young normotensive men carrying the 825T-allele of the G-protein beta3 subunit. Pharmacogenetics 2001;11:461–470.

    Article  PubMed  CAS  Google Scholar 

  14. Zeltner R, Delles C, Schneider M, et al. G-protein beta(3) subunit gene (GNB3) 825T allele is associated with enhanced renal perfusion in early hypertension. Hypertension 2001; 37:882–886.

    PubMed  CAS  Google Scholar 

  15. Dobrev D, Wettwer E, Himmel HM, et al. G-protein beta(3)-subunit 825T allele is associated with enhanced human atrial inward rectifier potassium currents. Circulation 2000;102:692–697.

    PubMed  CAS  Google Scholar 

  16. Hauner H, Rohrig K, Siffert W. Effects of the G-protein beta3 subunit 825T allele on adipogenesis and lipolysis in cultured human preadipocytes and adipocytes. Horm Metab Res 2002; 34:475–480.

    Article  PubMed  CAS  Google Scholar 

  17. Ryden M, Faulds G, Hoffstedt J, et al. Effect of the (C825T) Gbeta(3) polymorphism on adrenoceptor-mediated lipolysis in human fat cells. Diabetes 2002;51:1601–1608.

    Article  PubMed  CAS  Google Scholar 

  18. Lindemann M, Virchow S, Ramann F, et al. The G protein beta3 subunit 825T allele is a genetic marker for enhanced T cell response. FEBS Lett 2001;495:82–86.

    Article  PubMed  CAS  Google Scholar 

  19. Morrison AC, Doris PA, Folsom AR, et al. Atherosclerosis Risk in Communities Study. G-protein beta3 subunit and alpha-adducin polymorphisms and risk of subclinical and clinical stroke. Stroke 2001;32:822–829.

    PubMed  CAS  Google Scholar 

  20. Poch E, Gonzalez D, Gomez-Angelats E, et al. G-Protein beta(3) subunit gene variant and left ventricular hypertrophy in essential hypertension. Hypertension 2000;35:214–218.

    PubMed  CAS  Google Scholar 

  21. Siffert W, Forster P, Jöckel K-H, et al. Worldwide ethnic distribution of the G protein γ3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. J Am Soc Nephrol 1999;10:1021–1030.

    Google Scholar 

  22. Gutersohn A, Naber C, Muller N, et al. G-protein beta3 825TT genotype and post-pregnancy weight retention. Lancet 2000;51:1601–1608.

    Google Scholar 

  23. Hocher B, Slowinski T, Stolze T, et al. Association of maternal G protein beta3 subunit 825T allele with low birthweight. Lancet 2000;355:1241–1242.

    Article  PubMed  CAS  Google Scholar 

  24. Beige J, Engeli S, Ringel J, et al. Donor G protein beta3 subunit 825TT genotype is associated with reduced kidney allograft survival. J Am Soc Nephrol 1999;10:1717–1721.

    PubMed  CAS  Google Scholar 

  25. Kato N, Sugiyama T, Morita H, et al. G-protein b3 subunit variant and essential hypertension in Japanese. Hypertension 1998;32:935–938.

    PubMed  CAS  Google Scholar 

  26. Larson N, Hutchinson R, Boerwinkle E. Lack of association of 3 functional gene variants with hypertension in African Americans. Hypertension 2000;35:1297–1300.

    PubMed  CAS  Google Scholar 

  27. Snapir A, Heinonen P, Tuomainen TP, et al. G-protein b3 subunit C825T polymorphism: No association with risk for hypertension and obesity. J Hypertens 2001;19:2149–2155.

    Article  PubMed  CAS  Google Scholar 

  28. Benjafield AV, Lin RCY, Dalziel B, et al. G-protein b3 subunit gene splice variant in obesity and overweight. Int J Obes 2001;25:777–780.

    Article  CAS  Google Scholar 

  29. Rosskopf D, Busch S, Manthey I, et al. G protein b3 gene: Structure, promoter, and additional polymorphisms. Hypertension 2000;36:33–41.

    PubMed  CAS  Google Scholar 

  30. Sokel RR, Rolf FJ. Biometry. New York: WH Freeman and Co, 1981, p 765.

    Google Scholar 

  31. Branson R, Potoczna N, Kral JG, et al. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. N Engl J Med 2003;348:1096–1103.

    Article  PubMed  CAS  Google Scholar 

  32. Hauri P, Steffen R, Ricklin T, et al. Treatment of morbid obesity with the Swedish Adjustable Gastric Band (SAGB): Complication rate during a 12-month follow-up period. Surgery 2000;127:484–488.

    Article  PubMed  CAS  Google Scholar 

  33. Wiesner W, Weber M, Hauser RS, et al. Anterior versus posterior slippage: Two different types of eccentric pouch dilatation in patients with adjustable gastric banding. Dig Surg 2001;18:182–186.

    Article  PubMed  CAS  Google Scholar 

  34. James WP, Astrup A, Finer N, et al. Effect of sibutramine on weight maintenance after weight loss: A randomised trial. Lancet 2000;356:2119–2125.

    Article  PubMed  CAS  Google Scholar 

  35. Zoss I, Piec G, Horber FF. Impact of orlistat therapy on weight reduction in morbidly obese patients after implantation of the Swedish Adjustable Gastric Band. Obes Surg 2002;12:113–117.

    Article  PubMed  Google Scholar 

  36. Steffen R, Horber F, Hauri P. Swedish Adjustable Gastric Band (SAGB)-distal gastric bypass: A new variant of an old technique in the treatment of superobesty and failed band restriction. Obes Surg 1999;9:171–176.

    Article  PubMed  CAS  Google Scholar 

  37. Gagner M, Steffen R, Biertho L, et al. Laparoscopic adjustable gastric banding with duodenal switch for morbid obesity: Technique and preliminary results. Obes Surg 2003;13:444–449.

    Article  PubMed  Google Scholar 

  38. Hellmich N. Obesity on track as No. 1 killer. USA Today. Available at: http://www.usatoday.com/news/health/2004-03-09-obesity_x.htm. Accessed September 12, 2004.

  39. O’Brien PE, Dixon JB. Lap-band: Outcomes and results. J Laparoendosc Adv Surg Tech A 2003;13:265–270.

    Article  PubMed  Google Scholar 

  40. Kral JG, Branson R, Piec G, et al. Melanocortin-4 receptor gene variants affect results of gastric banding. J GASTROINTEST SURG 2004;126(Suppl 2):A774.

    Google Scholar 

  41. Kral JG, Lentes K-U, Horber FF. Binge eating as a phenotype of melanocortin 4 receptor gene mutations. N Engl J Med 2003;349:606–609; author reply 606-609.

    Article  Google Scholar 

  42. Davy KP, Hall JE. Obesity and hypertension: Two epidemics or one? Am J Physiol Regul Integr Comp Physiol 2004;286:R803-R813.

    PubMed  CAS  Google Scholar 

  43. Siffert W, Rosskopf D, Erbel R. Genetic polymorphism of the G-protein beta3 subunit, obesity and essential hypertension. Herz 2000;25:26–33.

    Article  PubMed  CAS  Google Scholar 

  44. Stevens VJ, Obarzanek E, Cook NR, et al. Long-term weight loss and changes in blood pressure: Results of the Trials of Hypertension Prevention, phase II. Ann Intern Med 2001; 134:1–11.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik Hirslanden, Witellikerstrasse 40, CH-8008, Zurich, Switzerland

    Natascha Potoczna M.D., Maria Wertli M.S., M.D. & Fritz F. Horber M.D.

  2. Obex Institute, Zurich and Bern, Switzerland

    Rudolph Steffen M.D., Thomas Ricklin M.D. & Fritz F. Horber M.D.

  3. Bioscientia GmbH, Ingelheim, Germany

    Klaus-Ulrich Lentes Ph.D.

Authors
  1. Natascha Potoczna M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Wertli M.S., M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rudolph Steffen M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Thomas Ricklin M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Klaus-Ulrich Lentes Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Fritz F. Horber M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Potoczna, N., Wertli, M., Steffen, R. et al. G protein polymorphisms do not predict weight loss and improvement of hypertension in severely obese patients. J Gastrointest Surg 8, 862–868 (2004). https://doi.org/10.1016/j.gassur.2004.08.004

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1016/j.gassur.2004.08.004

Key words

Search

Navigation